James C. Garbutt

5.9k total citations · 1 hit paper
92 papers, 4.3k citations indexed

About

James C. Garbutt is a scholar working on Cellular and Molecular Neuroscience, Epidemiology and Behavioral Neuroscience. According to data from OpenAlex, James C. Garbutt has authored 92 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cellular and Molecular Neuroscience, 22 papers in Epidemiology and 18 papers in Behavioral Neuroscience. Recurrent topics in James C. Garbutt's work include Neurotransmitter Receptor Influence on Behavior (25 papers), Substance Abuse Treatment and Outcomes (21 papers) and Stress Responses and Cortisol (18 papers). James C. Garbutt is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (25 papers), Substance Abuse Treatment and Outcomes (21 papers) and Stress Responses and Cortisol (18 papers). James C. Garbutt collaborates with scholars based in United States, Ireland and Japan. James C. Garbutt's co-authors include Alexey B. Kampov‐Polevoy, Alexei B. Kampov‐Polevoy, David R. Gastfriend, Daniel E Jonas, Robert Gallop, Halle R Amick, Helen M. Pettinati, David S. Janowsky, Henry R. Kranzler and Stephanie S. O’Malley and has published in prestigious journals such as JAMA, Annals of Internal Medicine and American Journal of Psychiatry.

In The Last Decade

James C. Garbutt

87 papers receiving 4.1k citations

Hit Papers

Pharmacotherapy for Adults With Alcohol Use Disorders in ... 2014 2026 2018 2022 2014 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James C. Garbutt United States 30 1.6k 1.2k 867 562 550 92 4.3k
Raye Z. Litten United States 37 2.1k 1.3× 1.2k 0.9× 1.1k 1.3× 344 0.6× 233 0.4× 79 4.4k
Michael Soyka Germany 28 1.3k 0.8× 720 0.6× 510 0.6× 397 0.7× 561 1.0× 136 3.1k
Barbara J. Mason United States 40 2.2k 1.4× 1.8k 1.4× 958 1.1× 718 1.3× 507 0.9× 112 6.0k
Stephanie S. O’Malley United States 38 2.1k 1.3× 1.8k 1.4× 847 1.0× 423 0.8× 512 0.9× 114 5.6k
Joanne B. Fertig United States 29 1.6k 0.9× 880 0.7× 827 1.0× 228 0.4× 252 0.5× 57 3.8k
Carrie L. Randall United States 39 2.7k 1.6× 1.3k 1.0× 902 1.0× 502 0.9× 534 1.0× 114 6.6k
Gerhard A. Wiesbeck Switzerland 34 924 0.6× 776 0.6× 682 0.8× 271 0.5× 295 0.5× 127 3.4k
Hugh Myrick United States 42 1.2k 0.7× 1.7k 1.4× 320 0.4× 892 1.6× 334 0.6× 84 4.8k
Nassima Ait‐Daoud United States 31 1.3k 0.8× 1.8k 1.4× 603 0.7× 534 1.0× 202 0.4× 85 3.7k
Daniel E. Falk United States 28 1.8k 1.1× 715 0.6× 861 1.0× 223 0.4× 284 0.5× 46 3.0k

Countries citing papers authored by James C. Garbutt

Since Specialization
Citations

This map shows the geographic impact of James C. Garbutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Garbutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Garbutt more than expected).

Fields of papers citing papers by James C. Garbutt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James C. Garbutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Garbutt. The network helps show where James C. Garbutt may publish in the future.

Co-authorship network of co-authors of James C. Garbutt

This figure shows the co-authorship network connecting the top 25 collaborators of James C. Garbutt. A scholar is included among the top collaborators of James C. Garbutt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James C. Garbutt. James C. Garbutt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garbutt, James C., et al.. (2021). Efficacy and tolerability of baclofen in a U.S. community population with alcohol use disorder: a dose-response, randomized, controlled trial. Neuropsychopharmacology. 46(13). 2250–2256. 46 indexed citations
2.
Jonas, Daniel E & James C. Garbutt. (2017). Screening and Counseling for Unhealthy Alcohol Use in Primary Care Settings. Medical Clinics of North America. 101(4). 823–837. 7 indexed citations
3.
Berger, Lisa, et al.. (2016). Alcohol Use Disorder Treatment: The Association of Pretreatment Use and the Role of Drinking Goal. The Journal of the American Board of Family Medicine. 29(1). 37–49. 12 indexed citations
4.
Jonas, Daniel E, James C. Garbutt, Halle R Amick, et al.. (2012). Behavioral Counseling After Screening for Alcohol Misuse in Primary Care: A Systematic Review and Meta-analysis for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 157(9). 645–654. 296 indexed citations
5.
Garbutt, James C.. (2010). Efficacy and Tolerability of Naltrexone in the Management of Alcohol Dependence. Current Pharmaceutical Design. 16(19). 2091–2097. 68 indexed citations
6.
Dichter, Gabriel S., Moria J. Smoski, Alexey B. Kampov‐Polevoy, Robert Gallop, & James C. Garbutt. (2010). Unipolar depression does not moderate responses to the Sweet Taste Test. Depression and Anxiety. 27(9). 859–863. 124 indexed citations
7.
Gastfriend, David R., James C. Garbutt, Helen M. Pettinati, & Robert Forman. (2007). Reduction in heavy drinking as a treatment outcome in alcohol dependence. Journal of Substance Abuse Treatment. 33(1). 71–80. 102 indexed citations
8.
O’Malley, Stephanie S., James C. Garbutt, David R. Gastfriend, Qunming Dong, & Henry R. Kranzler. (2007). Efficacy of Extended-Release Naltrexone in Alcohol-Dependent Patients Who Are Abstinent Before Treatment. Journal of Clinical Psychopharmacology. 27(5). 507–512. 93 indexed citations
9.
Garbutt, James C.. (2006). Emerging Pharmacologic Treatments for Alcohol Dependence. The Journal of Clinical Psychiatry. 67. 35–40. 2 indexed citations
10.
Garbutt, James C., Henry R. Kranzler, Stephanie S. O’Malley, et al.. (2005). Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence. JAMA. 293(13). 1617–1617. 461 indexed citations
11.
Kampov‐Polevoy, Alexey B., et al.. (2005). Sweet preference predicts mood altering effect of and impaired control over eating sweet foods. Eating Behaviors. 7(3). 181–187. 84 indexed citations
12.
Garbutt, James C., et al.. (2001). Tratamiento farmacológico de la dependencia alcohólica: una revisión de los hechos. 3–14.
13.
West, Suzanne L, James C. Garbutt, Timothy S. Carey, et al.. (1999). Pharmacotherapy for alcohol dependence.. PubMed. 1–5. 20 indexed citations
14.
Garbutt, James C., et al.. (1996). Dose‐Response Studies with Thyrotropin‐Releasing Hormone: Evidence for Differential Pituitary Responses in Men with Major Depression, Alcoholism, or No Psychopathology. Alcoholism Clinical and Experimental Research. 20(4). 717–722. 11 indexed citations
15.
Garbutt, James C., et al.. (1995). Thyrotropin and Prolactin Responses to Thyrotropin‐Releasing Hormone in Young Men at High or Low Risk for Alcoholism. Alcoholism Clinical and Experimental Research. 19(5). 1133–1140. 6 indexed citations
16.
Mason, George, et al.. (1994). The Subchronic Effects of the TRH Analog TA‐0910 and Bromocriptine on Alcohol Preference in Alcohol‐Preferring Rats: Development of Tolerance and Cross‐Tolerance. Alcoholism Clinical and Experimental Research. 18(5). 1196–1201. 24 indexed citations
17.
Rezvani, Amir H., et al.. (1992). Attenuation of Alcohol Preference in Alcohol‐Preferring Rats by a Novel TRH Analogue, TA‐0910. Alcoholism Clinical and Experimental Research. 16(2). 326–330. 31 indexed citations
18.
Garbutt, James C., et al.. (1991). Behavioral and Endocrine Interactions between Thyrotropin‐Releasing Hormone and Ethanol in Normal Human Subjects. Alcoholism Clinical and Experimental Research. 15(6). 1045–1049. 3 indexed citations
19.
Shimoda, Kazutaka, et al.. (1991). Administration of chlordiazepoxide affects [3H][3-MeHis2]thyrotropin-releasing hormone binding in rat brain. Peptides. 12(1). 199–202. 4 indexed citations
20.
Little, Karley Y., James C. Garbutt, James P. Mayo, & George Mason. (1988). Lack of Acute <i>d</i>-Amphetamine Effects on Thyrotropin Release. Neuroendocrinology. 48(3). 304–307. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026